| 1 |
|
ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface/
|
Murciano, J.-C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2 |
|
Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels/
|
Suzuki, N
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 3 |
|
Identification of a gene expression signature associated with pediatric AML prognosis/
|
Yagi, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 4 |
|
Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A~2/
|
Boilard, E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 5 |
|
Identification of differentially expressed genes representing dendritic cell precursors and their progeny/
|
Wilson, H. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 6 |
|
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays/
|
Chauhan, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 7 |
|
Identification of in vitro growth conditions for c-Kit-negative hematopoietic stem cells/
|
Klarmann, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 8 |
|
Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI/
|
Okumura, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 9 |
|
Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion/
|
Kuppner, M. C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 10 |
|
IGF-1 down-regulates IFN-gammaR2 chain surface expression and desensitizes IFN-gamma/STAT-1 signaling in human T lymphocytes/
|
Bernabei, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 11 |
|
IL-10 and TGF-beta induce alloreactive CD4^+CD25^- T cells to acquire regulatory cell function/
|
Chen, Z
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 12 |
|
IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages/
|
Kuwata, H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 13 |
|
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1/
|
Barlic, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 14 |
|
IL-15 induces antigen-independent expansion and differentiation of human naive CD8^+ T cells in vitro/
|
Alves, N. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 15 |
|
IL-15 is an essential mediator of peripheral NK-cell homeostasis/
|
Ranson, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 16 |
|
IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-gamma expression in murine NK cells/
|
Bream, J. H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 17 |
|
Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions/
|
Huntly, B. J. P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 18 |
|
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta/
|
Garcia, J. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 19 |
|
Imatinib normalizes bone marrow vascularity in patients with chronic mycloid leukemia in first chronic phase/
|
Rumpel, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 20 |
|
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
|
Pardanani, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|